Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
serotonin save search
Treatment strategies for serotonin reuptake inhibitor-resistant obsessive-compulsive disorder: A network meta-analysis of randomised controlled trials
Published: 2023-11-22 (Crawled : 15:30) - brainsway.com
BWAY | $4.835 0.94% 0.93% 41K
|
Health Technology
|
| O: -1.61%
H: 15.31%
C: 12.45%
treatment trials serotonin network
Serotonin Centers Opens Doors to First of 5 Franchise Locations Across Central New Jersey
Published: 2023-06-22 (Crawled : 13:00) - prnewswire.com
FNCTF | News | $11.0354 -20.84% 320
|
Communications
| Email alert
Add to watchlist
serotonin
Reviva Pharmaceuticals Presented Foundational Preclinical Data on Novel Serotonin-Dopamine Stabilizer Brilaroxazine at the 78th Annual SOBP and Publication in Medical Research Archives
Published: 2023-05-01 (Crawled : 20:00) - globenewswire.com
RVPH | $3.035 0.5% 0.49% 140K
|
|
| O: -1.08%
H: 2.18%
C: -3.13%
brilaroxazine publication pharmaceuticals research preclinical medical
Serotonin Centers Announces 10-Unit Development Agreement for Orange County
Published: 2023-04-25 (Crawled : 14:20) - prnewswire.com
FNCTF | News | $11.0354 -20.84% 320
|
Communications
| Email alert
Add to watchlist
serotonin agreement
Bright Minds Biosciences to Present at the 20th International Meeting of the International Society for Serotonin Research
Published: 2023-04-10 (Crawled : 11:00) - globenewswire.com
DRUG | $1.25 -6.61% 11K
|
Manufacturing
|
| O: 4.55%
H: 2.17%
C: -0.02%
international research meeting serotonin
The Serotonin Theory of Depression
Published: 2023-01-30 (Crawled : 12:00) - brainsway.com
BWAY | $4.835 0.94% 0.93% 41K
|
Health Technology
|
| O: 1.0%
H: 0.47%
C: -0.99%
serotonin depression
What Is Serotonin Syndrome? Symptoms And Treatment Options
Published: 2023-01-30 (Crawled : 12:00) - brainsway.com
BWAY | $4.835 0.94% 0.93% 41K
|
Health Technology
|
| O: 1.0%
H: 0.47%
C: -0.99%
treatment serotonin
Depression Drugs Market to Surpass US$ 20 Billion by 2031 as Demand for Serotonin-norepinephrine Reuptake Inhibitors Surges
Published: 2022-08-11 (Crawled : 14:00) - prnewswire.com
TEVJF | News | $12.37 -24.22% 380
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -1.83%
H: 0.79%
C: -0.29%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -1.18%
H: 1.46%
C: 0.05%
ALKS | $23.86 0.42% 0.42% 2.4M
|
Health Technology
|
| O: -0.08%
H: 0.51%
C: -0.62%
depression market
Adial Pharmaceuticals Receives Notice of Allowance on U.S. Patent for the Treatment for Opioid Use Disorder Using AD04Patent covers patients with a specific genetic biomarker for the serotonin-3 receptor
Published: 2022-01-24 (Crawled : 15:00) - biospace.com/
ADIL | $1.9 -12.44% -14.21% 310K
|
Health Technology
|
| O: -3.42%
H: 4.87%
C: 3.98%
ad04 treatment genetic als serotonin-3 order patent opioid biomarkers
Selective Serotonin Reuptake Inhibitors (SSRIs) Market- AbbVie Inc., Apotex Inc., Aurobindo Pharma Ltd., among others to contribute to the market growth|Industry Analysis, Market Trends, Opportunities and Forecast 2025
Published: 2021-04-02 (Crawled : 03:00) - prnewswire.com
BHC | $8.69 1.05% 0.0% 2.9M
|
Health Technology
| Email alert
Add to watchlist
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
| Email alert
Add to watchlist
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
| Email alert
Add to watchlist
growth
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.